Analytics
Under the multiyear strategic partnership Anumana will conduct a clinical-validation trial and seek FDA De Novo classification for the algorithm.
According to TechCrunch and Fierce Healthcare, the health data company also recently closed a $200 million structured equity infusion.
The company pitches iQuest as a way for physicians to provide more precise cancer treatment and lessen the likelihood of negative side effects.
EchoSolv accurately identifies patients with guideline-defined aortic stenosis using AI.
The company said it will use the capital to hire for its commercial teams and advance development on new features.
EchoGo Heart Failure, developed in partnership with the Mayo Clinic, helps physicians detect heart failure with preserved ejection fraction.
Also, AIRS Medical has proved the capability of its AI MRI reconstruction tool to denoise and improve the quality of 3D MR images.
Its acquisition is expected to close in the coming days.
The funding brings the Munich-based startup's total Series B raise to €42 million.
Its AI imaging solutions are coming soon to CARPL.ai's platform.